Reviewed By
Overview
SCIENTIFIC SCORE
Likely Very Effective
Based on 4 Researches
9
USERS' SCORE
Good
Based on 17 Reviews
8.4
Supplement Facts
Serving Size: 3 tablets
Amount Per Serving
%DV
Protease (4,800 USP)
3 mg
**
Bromelain (0.2 GDU)
3 mg
**
Alpha Amylase (120 DU)
3 mg
**
Cellulase Enzyme (9 ACU)
94.5 mg
**
Papain (90,000 USP)
45 mg
**
Lipase (12 USP)
1.5 mg
**
Papaya Fruit
15 mg
**
Sodium Copper Chlorophyllin (Chlorophyll)
1.5 mg
**
Top Medical Research Studies
9
We explored a new vaccine approach using papaya mosaic virus particles fused with a short influenza peptide. This innovative structure showed promise in generating strong immune responses after just one dose in mice. The results indicated that vaccinated mice were significantly protected from the flu, suggesting that this could pave the way for an effective, broadly protective vaccine. While the study used mouse models, the findings could provide insights into future influenza vaccine development.
Read More
8
We explored how papaya mosaic virus (PapMV) nanoparticles can enhance the immune response to the flu vaccine in a study involving mice and ferrets. Adding PapMV nanoparticles as an adjuvant led to a quicker and stronger antibody response, measurable just five days post-vaccination.
Importantly, these nanoparticles helped protect against lethal flu infections within just ten days of vaccination. This rapid response is particularly critical during pandemics when swift immunity is vital.
Importantly, these nanoparticles helped protect against lethal flu infections within just ten days of vaccination. This rapid response is particularly critical during pandemics when swift immunity is vital.
Read More
9.5
We investigated the possibility of using papaya mosaic virus (PapMV) as a platform for a universal influenza vaccine. Our research demonstrated that the PapMV-CP-M2e vaccine can effectively trigger mice's immune response, producing antibodies that target influenza-infected cells.
While the vaccine showed great promise, particularly when combined with adjuvants like alum, our focus emphasized the enhanced immunogenicity of the virus-like particles (VLPs). This study marks a significant advancement in vaccine development, showcasing the potential of plant virus proteins in combating influenza.
While the vaccine showed great promise, particularly when combined with adjuvants like alum, our focus emphasized the enhanced immunogenicity of the virus-like particles (VLPs). This study marks a significant advancement in vaccine development, showcasing the potential of plant virus proteins in combating influenza.
Read More
Most Useful Reviews
9
No more heartburn
7 people found this helpful
I've suffered from acid reflux for the past three years, which has been rather bothersome. During the night, I would awaken in pain and reach for TUMS to settle down. A friend suggested papaya enzyme, and since starting it a week ago, I'm now heartburn-free! I no longer wake in discomfort, and this product has truly been life-changing.
Read More
10
Significant reduction
4 people found this helpful
This product has reduced my severe acid reflux by 90%. Older individuals often lack sufficient stomach acid for digestion, which leads to food refluxing along with minimal acid present. This product is ideal for those like me, and I highly recommend it.
Read More
9
Great for reflux
3 people found this helpful
I’m thrilled I tried these! I felt extremely unwell with stomach acid reflux, and nexium wasn’t much help. After some research, I found the super papaya enzymes. Within 15 minutes of chewing three, my stomach felt significantly better. It’s been two weeks now, and I’m feeling fantastic!
Read More
Medical Researches
SCIENTIFIC SCORE
Likely Very Effective
Based on 4 Researches
9
- All Researches
9.5
We explored the potential of using papaya mosaic virus nanoparticles as an adjuvant to boost seasonal flu vaccines. The study involved immunizing mice and ferrets, which showed a stronger immune response to the flu virus, particularly in terms of recognized viral proteins. This method not only improved antibody production but also initiated robust cellular immunity. Overall, the findings suggest that papaya nanoparticles could significantly enhance flu vaccine effectiveness, potentially offering broader protection during outbreaks.
Read More
9.5
We investigated the possibility of using papaya mosaic virus (PapMV) as a platform for a universal influenza vaccine. Our research demonstrated that the PapMV-CP-M2e vaccine can effectively trigger mice's immune response, producing antibodies that target influenza-infected cells.
While the vaccine showed great promise, particularly when combined with adjuvants like alum, our focus emphasized the enhanced immunogenicity of the virus-like particles (VLPs). This study marks a significant advancement in vaccine development, showcasing the potential of plant virus proteins in combating influenza.
While the vaccine showed great promise, particularly when combined with adjuvants like alum, our focus emphasized the enhanced immunogenicity of the virus-like particles (VLPs). This study marks a significant advancement in vaccine development, showcasing the potential of plant virus proteins in combating influenza.
Read More
9
We explored a new vaccine approach using papaya mosaic virus particles fused with a short influenza peptide. This innovative structure showed promise in generating strong immune responses after just one dose in mice. The results indicated that vaccinated mice were significantly protected from the flu, suggesting that this could pave the way for an effective, broadly protective vaccine. While the study used mouse models, the findings could provide insights into future influenza vaccine development.
Read More
8
We explored how papaya mosaic virus (PapMV) nanoparticles can enhance the immune response to the flu vaccine in a study involving mice and ferrets. Adding PapMV nanoparticles as an adjuvant led to a quicker and stronger antibody response, measurable just five days post-vaccination.
Importantly, these nanoparticles helped protect against lethal flu infections within just ten days of vaccination. This rapid response is particularly critical during pandemics when swift immunity is vital.
Importantly, these nanoparticles helped protect against lethal flu infections within just ten days of vaccination. This rapid response is particularly critical during pandemics when swift immunity is vital.
Read More
User Reviews
USERS' SCORE
Good
Based on 17 Reviews
8.4
- All Reviews
- Positive Reviews
- Negative Reviews
9
No more heartburn
7 people found this helpful
I've suffered from acid reflux for the past three years, which has been rather bothersome. During the night, I would awaken in pain and reach for TUMS to settle down. A friend suggested papaya enzyme, and since starting it a week ago, I'm now heartburn-free! I no longer wake in discomfort, and this product has truly been life-changing.
Read More
10
Significant reduction
4 people found this helpful
This product has reduced my severe acid reflux by 90%. Older individuals often lack sufficient stomach acid for digestion, which leads to food refluxing along with minimal acid present. This product is ideal for those like me, and I highly recommend it.
Read More
9
Great for reflux
3 people found this helpful
I’m thrilled I tried these! I felt extremely unwell with stomach acid reflux, and nexium wasn’t much help. After some research, I found the super papaya enzymes. Within 15 minutes of chewing three, my stomach felt significantly better. It’s been two weeks now, and I’m feeling fantastic!
Read More
9
Natural reflux remedy
3 people found this helpful
These enzyme tablets are truly remarkable. I was seeking a natural remedy for my acid reflux to stop taking Pepcid. I tried several natural alternatives, but these tablets were the only ones that worked. I consume a few after every meal and before bed, and they taste delightful - minty!
Read More
9
Eliminated acid reflux
2 people found this helpful
As I reached middle age, I began having issues digesting oily and spicy foods. Now, these enzymes are my secret weapon! I take 1-2 before meals and 2-4 afterward, managing to eliminate my acid reflux entirely.
Read More
Frequently Asked Questions
10
Significant reduction
4 people found this helpful
This product has reduced my severe acid reflux by 90%. Older individuals often lack sufficient stomach acid for digestion, which leads to food refluxing along with minimal acid present. This product is ideal for those like me, and I highly recommend it.
9
No side effects
1 people found this helpful
Excellent! I received my order today. They're easy to take, the taste is quite palatable, and there’s no acid reflux when taken regularly. It functions well with no side effects.
9
Medication-free relief
My husband suffered from severe heartburn while on Prilosec for years. This product, combined with Reflux Away, has allowed him to completely stop taking medications!
7.5
Immediate relief
1 people found this helpful
These are helping me a lot. I experience acid reflux almost every time I eat, but taking just one after a meal resolves the issue immediately.
4
No significant effect
The papaya enzyme chewable tablet was used to treat my acid reflux, but I found the effect to be minimal. Although the ingredients are natural, it did not notably alleviate my symptoms.
8
We explored how papaya mosaic virus (PapMV) nanoparticles can enhance the immune response to the flu vaccine in a study involving mice and ferrets. Adding PapMV nanoparticles as an adjuvant led to a quicker and stronger antibody response, measurable just five days post-vaccination.
Importantly, these nanoparticles helped protect against lethal flu infections within just ten days of vaccination. This rapid response is particularly critical during pandemics when swift immunity is vital.
Importantly, these nanoparticles helped protect against lethal flu infections within just ten days of vaccination. This rapid response is particularly critical during pandemics when swift immunity is vital.
9
We explored a new vaccine approach using papaya mosaic virus particles fused with a short influenza peptide. This innovative structure showed promise in generating strong immune responses after just one dose in mice. The results indicated that vaccinated mice were significantly protected from the flu, suggesting that this could pave the way for an effective, broadly protective vaccine. While the study used mouse models, the findings could provide insights into future influenza vaccine development.
9.5
We explored the potential of using papaya mosaic virus nanoparticles as an adjuvant to boost seasonal flu vaccines. The study involved immunizing mice and ferrets, which showed a stronger immune response to the flu virus, particularly in terms of recognized viral proteins. This method not only improved antibody production but also initiated robust cellular immunity. Overall, the findings suggest that papaya nanoparticles could significantly enhance flu vaccine effectiveness, potentially offering broader protection during outbreaks.
9.5
We investigated the possibility of using papaya mosaic virus (PapMV) as a platform for a universal influenza vaccine. Our research demonstrated that the PapMV-CP-M2e vaccine can effectively trigger mice's immune response, producing antibodies that target influenza-infected cells.
While the vaccine showed great promise, particularly when combined with adjuvants like alum, our focus emphasized the enhanced immunogenicity of the virus-like particles (VLPs). This study marks a significant advancement in vaccine development, showcasing the potential of plant virus proteins in combating influenza.
While the vaccine showed great promise, particularly when combined with adjuvants like alum, our focus emphasized the enhanced immunogenicity of the virus-like particles (VLPs). This study marks a significant advancement in vaccine development, showcasing the potential of plant virus proteins in combating influenza.
References
- Rioux G, Carignan D, Russell A, Bolduc M, Gagné MÈ, et al. Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine. J Nanobiotechnology. 2016;14:43. 10.1186/s12951-016-0200-2
- Carignan D, Thérien A, Rioux G, Paquet G, Gagné ML, et al. Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine. Vaccine. 2015;33:7245. 10.1016/j.vaccine.2015.10.123
- Savard C, Guérin A, Drouin K, Bolduc M, Laliberté-Gagné ME, et al. Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles. PLoS One. 2011;6:e21522. 10.1371/journal.pone.0021522
- Denis J, Acosta-Ramirez E, Zhao Y, Hamelin ME, Koukavica I, et al. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine. 2008;26:3395. 10.1016/j.vaccine.2008.04.052
